Using digital spatial profiling, it was also recently shown that after intratumoral injection of STING-activating nanoparticles, the expression of B7-H3 and S100A9 immune checkpoints, which are associated with tumor immune evasion is increased. Here, S100A9 is linked to neoplasm.